{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:28:03Z","timestamp":1791959283342,"version":"4.3.4"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medical University of Vienna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12016-017-8619-2","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T04:55:19Z","timestamp":1500440119000},"page":"397-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Mastocytosis: from a Molecular Point of View"],"prefix":"10.1007","volume":"54","author":[{"given":"Daniel Elieh Ali","family":"Komi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Rambasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6324-0007","authenticated-orcid":false,"given":"Stefan","family":"W\u00f6hrl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"issue":"3","key":"8619_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/mi.2014.131","volume":"8","author":"LL Reber","year":"2015","unstructured":"Reber LL, Sibilano R, Mukai K, Galli SJ (2015) Potential effector and immunoregulatory functions of mast cells in mucosal immunity. Mucosal Immunol 8(3):444\u2013463. doi: 10.1038\/mi.2014.131","journal-title":"Mucosal Immunol"},{"issue":"12","key":"8619_CR2","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1369\/0022155412458927","volume":"60","author":"E Ronnberg","year":"2012","unstructured":"Ronnberg E, Melo FR, Pejler G (2012) Mast cell proteoglycans. J Histochem Cytochem Off J Histochem Soc 60(12):950\u2013962. doi: 10.1369\/0022155412458927","journal-title":"J Histochem Cytochem Off J Histochem Soc"},{"issue":"2","key":"8619_CR3","first-page":"159","volume":"3","author":"P Valent","year":"2013","unstructured":"Valent P (2013) Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology. Am J Cancer Res 3(2):159\u2013172","journal-title":"Am J Cancer Res"},{"issue":"1","key":"8619_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.iac.2013.09.001","volume":"34","author":"MC Carter","year":"2014","unstructured":"Carter MC, Metcalfe DD, Komarow HD (2014) Mastocytosis. Immunol Allergy Clin N Am 34(1):181\u2013196. doi: 10.1016\/j.iac.2013.09.001","journal-title":"Immunol Allergy Clin N Am"},{"key":"8619_CR5","first-page":"65","volume":"8","author":"D Magliacane","year":"2014","unstructured":"Magliacane D, Parente R, Triggiani M (2014) Current concepts on diagnosis and treatment of mastocytosis. Translat Med @ UniSa 8:65\u201374","journal-title":"Translat Med @ UniSa"},{"issue":"12","key":"8619_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/j.1365-2362.2008.02047.x","volume":"38","author":"NM Kushnir-Sukhov","year":"2008","unstructured":"Kushnir-Sukhov NM, Brittain E, Scott L, Metcalfe DD (2008) Clinical correlates of blood serotonin levels in patients with mastocytosis. Eur J Clin Investig 38(12):953\u2013958. doi: 10.1111\/j.1365-2362.2008.02047.x","journal-title":"Eur J Clin Investig"},{"issue":"3","key":"8619_CR7","doi-asserted-by":"publisher","first-page":"533","DOI":"10.5114\/aoms.2012.29409","volume":"8","author":"M Lange","year":"2012","unstructured":"Lange M, Nedoszytko B, Gorska A, Zawrocki A, Sobjanek M, Kozlowski D (2012) Mastocytosis in children and adults: clinical disease heterogeneity. Arch Med Sci 8(3):533\u2013541. doi: 10.5114\/aoms.2012.29409","journal-title":"Arch Med Sci"},{"key":"8619_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/978-1-4419-9533-9_1","volume":"716","author":"AM Gilfillan","year":"2011","unstructured":"Gilfillan AM, Austin SJ, Metcalfe DD (2011) Mast cell biology: introduction and overview. Adv Exp Med Biol 716:2\u201312. doi: 10.1007\/978-1-4419-9533-9_1","journal-title":"Adv Exp Med Biol"},{"issue":"15","key":"8619_CR9","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1517\/14656566.2013.824424","volume":"14","author":"JC Cardet","year":"2013","unstructured":"Cardet JC, Akin C, Lee MJ (2013) Mastocytosis: update on pharmacotherapy and future directions. Expert Opin Pharmacother 14(15):2033\u20132045. doi: 10.1517\/14656566.2013.824424","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"8619_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.alit.2015.09.002","volume":"65","author":"SJ Galli","year":"2016","unstructured":"Galli SJ, Starkl P, Marichal T, Tsai M (2016) Mast cells and IgE in defense against venoms: possible \u201cgood side\u201d of allergy? Allergology Int Off J Jpn Soc Allergol 65(1):3\u201315. doi: 10.1016\/j.alit.2015.09.002","journal-title":"Allergology Int Off J Jpn Soc Allergol"},{"key":"8619_CR11","doi-asserted-by":"publisher","unstructured":"Elieh Ali Komi D, Shafaghat F, Zwiener RD (2017) Immunology of bee venom. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-017-8597-4","DOI":"10.1007\/s12016-017-8597-4"},{"key":"8619_CR12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fphar.2013.00174","volume":"4","author":"C Overed-Sayer","year":"2013","unstructured":"Overed-Sayer C, Rapley L, Mustelin T, Clarke DL (2013) Are mast cells instrumental for fibrotic diseases? Front Pharmacol 4:174. doi: 10.3389\/fphar.2013.00174","journal-title":"Front Pharmacol"},{"issue":"1","key":"8619_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","volume":"1822","author":"TC Theoharides","year":"2012","unstructured":"Theoharides TC, Alysandratos KD, Angelidou A, Delivanis DA, Sismanopoulos N, Zhang B, Asadi S, Vasiadi M, Weng Z, Miniati A, Kalogeromitros D (2012) Mast cells and inflammation. Biochim Biophys Acta 1822(1):21\u201333. doi: 10.1016\/j.bbadis.2010.12.014","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"8619_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jdermsci.2007.09.009","volume":"49","author":"SJ Galli","year":"2008","unstructured":"Galli SJ, Tsai M (2008) Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 49(1):7\u201319. doi: 10.1016\/j.jdermsci.2007.09.009","journal-title":"J Dermatol Sci"},{"issue":"2","key":"8619_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1385\/ir:34:2:97","volume":"34","author":"Y Okayama","year":"2006","unstructured":"Okayama Y, Kawakami T (2006) Development, migration, and survival of mast cells. Immunol Res 34(2):97\u2013115. doi: 10.1385\/ir:34:2:97","journal-title":"Immunol Res"},{"issue":"14","key":"8619_CR16","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1089\/scd.2014.0553","volume":"24","author":"JS Dahlin","year":"2015","unstructured":"Dahlin JS, Ding Z, Hallgren J (2015) Distinguishing mast cell progenitors from mature mast cells in mice. Stem Cells Dev 24(14):1703\u20131711. doi: 10.1089\/scd.2014.0553","journal-title":"Stem Cells Dev"},{"key":"8619_CR17","doi-asserted-by":"publisher","unstructured":"Elieh-Ali-Komi D, Cao Y (2016) Role of mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-016-8595-y","DOI":"10.1007\/s12016-016-8595-y"},{"key":"8619_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2012.00119","volume":"3","author":"I Halova","year":"2012","unstructured":"Halova I, Draberova L, Draber P (2012) Mast cell chemotaxis\u2014chemoattractants and signaling pathways. Front Immunol 3:119. doi: 10.3389\/fimmu.2012.00119","journal-title":"Front Immunol"},{"issue":"2","key":"8619_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.18632\/oncotarget.100602","volume":"1","author":"H Merz","year":"2010","unstructured":"Merz H, Kaehler C, Hoefig KP, Branke B, Uckert W, Nadrowitz R, Cerny-Reiterer S, Herrmann H, Feller AC, Valent P (2010) Interleukin-9 (IL-9) and NPM-ALK each generate mast cell hyperplasia as single \u2018hit\u2019 and cooperate in producing a mastocytosis-like disease in mice. Oncotarget 1(2):104\u2013119. doi: 10.18632\/oncotarget.100602","journal-title":"Oncotarget"},{"key":"8619_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fimmu.2012.00238","volume":"3","author":"H Migalovich-Sheikhet","year":"2012","unstructured":"Migalovich-Sheikhet H, Friedman S, Mankuta D, Levi-Schaffer F (2012) Novel identified receptors on mast cells. Front Immunol 3:238. doi: 10.3389\/fimmu.2012.00238","journal-title":"Front Immunol"},{"issue":"10","key":"8619_CR21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1369\/0022155414545334","volume":"62","author":"EZ Silva da","year":"2014","unstructured":"da Silva EZ, Jamur MC, Oliver C (2014) Mast cell function: a new vision of an old cell. J Histochem Cytochem Off J Histochem Soc 62(10):698\u2013738. doi: 10.1369\/0022155414545334","journal-title":"J Histochem Cytochem Off J Histochem Soc"},{"issue":"7","key":"8619_CR22","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1073\/pnas.0707854105","volume":"105","author":"N Puri","year":"2008","unstructured":"Puri N, Roche PA (2008) Mast cells possess distinct secretory granule subsets whose exocytosis is regulated by different SNARE isoforms. Proc Natl Acad Sci U S A 105(7):2580\u20132585. doi: 10.1073\/pnas.0707854105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"8619_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1365-2249.2008.03840.x","volume":"155","author":"A Wasiuk","year":"2009","unstructured":"Wasiuk A, de Vries VC, Hartmann K, Roers A, Noelle RJ (2009) Mast cells as regulators of adaptive immunity to tumours. Clin Exp Immunol 155(2):140\u2013146. doi: 10.1111\/j.1365-2249.2008.03840.x","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"8619_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nri3427","volume":"13","author":"D Voehringer","year":"2013","unstructured":"Voehringer D (2013) Protective and pathological roles of mast cells and basophils. Nat Rev Immunol 13(5):362\u2013375. doi: 10.1038\/nri3427","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"8619_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00018-010-0587-0","volume":"68","author":"A Lundequist","year":"2011","unstructured":"Lundequist A, Pejler G (2011) Biological implications of preformed mast cell mediators. Cell Mol Life Sci 68(6):965\u2013975. doi: 10.1007\/s00018-010-0587-0","journal-title":"Cell Mol Life Sci"},{"key":"8619_CR26","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3389\/fimmu.2014.00569","volume":"5","author":"TC Moon","year":"2014","unstructured":"Moon TC, Befus AD, Kulka M (2014) Mast cell mediators: their differential release and the secretory pathways involved. Front Immunol 5:569. doi: 10.3389\/fimmu.2014.00569","journal-title":"Front Immunol"},{"key":"8619_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fimmu.2012.00120","volume":"3","author":"G Gri","year":"2012","unstructured":"Gri G, Frossi B, D'Inca F, Danelli L, Betto E, Mion F, Sibilano R, Pucillo C (2012) Mast cell: an emerging partner in immune interaction. Front Immunol 3:120. doi: 10.3389\/fimmu.2012.00120","journal-title":"Front Immunol"},{"issue":"3","key":"8619_CR28","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12307-014-0152-8","volume":"8","author":"A Rigoni","year":"2015","unstructured":"Rigoni A, Colombo MP, Pucillo C (2015) The role of mast cells in molding the tumor microenvironment. Cancer Microenviron Off J Int Cancer Microenviron Soc 8(3):167\u2013176. doi: 10.1007\/s12307-014-0152-8","journal-title":"Cancer Microenviron Off J Int Cancer Microenviron Soc"},{"issue":"2","key":"8619_CR29","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jaci.2012.05.009","volume":"131","author":"B Schafer","year":"2013","unstructured":"Schafer B, Piliponsky AM, Oka T, Song CH, Gerard NP, Gerard C, Tsai M, Kalesnikoff J, Galli SJ (2013) Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice. The Journal of allergy and clinical immunology 131(2):541\u2013548. doi: 10.1016\/j.jaci.2012.05.009","journal-title":"The Journal of allergy and clinical immunology"},{"issue":"5","key":"8619_CR30","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.4049\/jimmunol.1500253","volume":"195","author":"S Balseiro-Gomez","year":"2015","unstructured":"Balseiro-Gomez S, Flores JA, Acosta J, Ramirez-Ponce MP, Ales E (2015) Identification of a new exo-endocytic mechanism triggered by corticotropin-releasing hormone in mast cells. J Immunol (Baltimore, Md: 1950) 195(5):2046\u20132056. doi: 10.4049\/jimmunol.1500253","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"12","key":"8619_CR31","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1586\/1744666x.2015.1086645","volume":"11","author":"G Ciprandi","year":"2015","unstructured":"Ciprandi G, Marseglia GL, Castagnoli R, Valsecchi C, Tagliacarne C, Caimmi S, Licari A (2015) From IgE to clinical trials of allergic rhinitis. Expert Rev Clin Immunol 11(12):1321\u20131333. doi: 10.1586\/1744666x.2015.1086645","journal-title":"Expert Rev Clin Immunol"},{"key":"8619_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/s0065-2776(08)00403-3","volume":"98","author":"J Rivera","year":"2008","unstructured":"Rivera J, Fierro NA, Olivera A, Suzuki R (2008) New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol 98:85\u2013120. doi: 10.1016\/s0065-2776(08)00403-3","journal-title":"Adv Immunol"},{"issue":"12","key":"8619_CR33","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1007\/s00018-015-1870-x","volume":"72","author":"JS Shin","year":"2015","unstructured":"Shin JS, Greer AM (2015) The role of FcepsilonRI expressed in dendritic cells and monocytes. Cell Mol Life Sci 72(12):2349\u20132360. doi: 10.1007\/s00018-015-1870-x","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"8619_CR34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1357-2725(99)00076-X","volume":"31","author":"LK Ashman","year":"1999","unstructured":"Ashman LK (1999) The biology of stem cell factor and its receptor C-kit. Int J Biochem Cell Biol 31(10):1037\u20131051","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"8619_CR35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01232978","volume":"17","author":"EN Geissler","year":"1991","unstructured":"Geissler EN, Liao M, Brook JD, Martin FH, Zsebo KM, Housman DE, Galli SJ (1991) Stem cell factor (SCF), a novel hematopoietic growth factor and ligand for c-kit tyrosine kinase receptor, maps on human chromosome 12 between 12q14.3 and 12qter. Somat Cell Mol Genet 17(2):207\u2013214","journal-title":"Somat Cell Mol Genet"},{"issue":"23","key":"8619_CR36","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.3748\/wjg.v18.i23.2929","volume":"18","author":"CG Bai","year":"2012","unstructured":"Bai CG, Hou XW, Wang F, Qiu C, Zhu Y, Huang L, Zhao J, Xu JJ, Ma DL (2012) Stem cell factor-mediated wild-type KIT receptor activation is critical for gastrointestinal stromal tumor cell growth. World J Gastroenterol 18(23):2929\u20132937. doi: 10.3748\/wjg.v18.i23.2929","journal-title":"World J Gastroenterol"},{"issue":"2","key":"8619_CR37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.iac.2014.01.002","volume":"34","author":"G Cruse","year":"2014","unstructured":"Cruse G, Metcalfe DD, Olivera A (2014) Functional deregulation of KIT: link to mast cell proliferative diseases and other neoplasms. Immunol Allergy Clin N Am 34(2):219\u2013237. doi: 10.1016\/j.iac.2014.01.002","journal-title":"Immunol Allergy Clin N Am"},{"key":"8619_CR38","doi-asserted-by":"crossref","unstructured":"Besmer P, Manova K, Duttlinger R, Huang EJ, Packer A, Gyssler C, Bachvarova RF (1993) The kit-ligand (steel factor) and its receptor c-kit\/W: pleiotropic roles in gametogenesis and melanogenesis. Development (Cambridge, England) Supplement:125\u2013137","DOI":"10.1242\/dev.119.Supplement.125"},{"issue":"3\u20134","key":"8619_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/10428190009087013","volume":"38","author":"S Moore","year":"2000","unstructured":"Moore S, McDiarmid LA, Hughes TP (2000) Stem cell factor and chronic myeloid leukemia CD34+ cells. Leuk Lymphoma 38(3\u20134):211\u2013220. doi: 10.3109\/10428190009087013","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"8619_CR40","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","volume":"92","author":"J Lennartsson","year":"2012","unstructured":"Lennartsson J, Ronnstrand L (2012) Stem cell factor receptor\/c-Kit: from basic science to clinical implications. Physiol Rev 92(4):1619\u20131649. doi: 10.1152\/physrev.00046.2011","journal-title":"Physiol Rev"},{"issue":"10","key":"8619_CR41","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1093\/carcin\/bgu162","volume":"35","author":"X Wang","year":"2014","unstructured":"Wang X, Ren H, Zhao T, Chen J, Sun W, Sun Y, Ma W, Wang J, Gao C, Gao S, Lang M, Jia L, Hao J (2014) Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection. Carcinogenesis 35(10):2283\u20132290. doi: 10.1093\/carcin\/bgu162","journal-title":"Carcinogenesis"},{"issue":"4","key":"8619_CR42","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","volume":"112","author":"DD Metcalfe","year":"2008","unstructured":"Metcalfe DD (2008) Mast cells and mastocytosis. Blood 112(4):946\u2013956. doi: 10.1182\/blood-2007-11-078097","journal-title":"Blood"},{"issue":"8","key":"8619_CR43","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/gene.2010.35","volume":"11","author":"JK Morales","year":"2010","unstructured":"Morales JK, Falanga YT, Depcrynski A, Fernando J, Ryan JJ (2010) Mast cell homeostasis and the JAK-STAT pathway. Genes Immun 11(8):599\u2013608. doi: 10.1038\/gene.2010.35","journal-title":"Genes Immun"},{"issue":"21","key":"8619_CR44","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.18632\/oncotarget.4213","volume":"6","author":"A Chatterjee","year":"2015","unstructured":"Chatterjee A, Ghosh J, Kapur R (2015) Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder. Oncotarget 6(21):18250\u201318264. doi: 10.18632\/oncotarget.4213","journal-title":"Oncotarget"},{"issue":"12","key":"8619_CR45","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20050807","volume":"202","author":"JP Zappulla","year":"2005","unstructured":"Zappulla JP, Dubreuil P, Desbois S, Letard S, Hamouda NB, Daeron M, Delsol G, Arock M, Liblau RS (2005) Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation. J Exp Med 202(12):1635\u20131641. doi: 10.1084\/jem.20050807","journal-title":"J Exp Med"},{"issue":"5","key":"8619_CR46","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/leu.2009.37","volume":"23","author":"A Tefferi","year":"2009","unstructured":"Tefferi A, Levine RL, Lim KH, Abdel-Wahab O, Lasho TL, Patel J, Finke CM, Mullally A, Li CY, Pardanani A, Gilliland DG (2009) Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia 23(5):900\u2013904. doi: 10.1038\/leu.2009.37","journal-title":"Leukemia"},{"issue":"1","key":"8619_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12308-009-0023-2","volume":"2","author":"ST Pullarkat","year":"2009","unstructured":"Pullarkat ST, Pullarkat V, Kroft SH, Wilson CS, Ahsanuddin AN, Mann KP, Thein M, Grody WW, Brynes RK (2009) Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia. J Hematop 2(1):27\u201333. doi: 10.1007\/s12308-009-0023-2","journal-title":"J Hematop"},{"issue":"1","key":"8619_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2332\/allergolint.12-OA-0450","volume":"62","author":"TR Kataoka","year":"2013","unstructured":"Kataoka TR, Fujimoto M, Moriyoshi K, Koyanagi I, Ueshima C, Kono F, Tsuruyama T, Okayama Y, Ra C, Haga H (2013) PD-1 regulates the growth of human mastocytosis cells. Allergol Int Off J Jpn Soc Allergol 62(1):99\u2013104. doi: 10.2332\/allergolint.12-OA-0450","journal-title":"Allergol Int Off J Jpn Soc Allergol"},{"issue":"5","key":"8619_CR49","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jaad.2015.09.029","volume":"74","author":"LF Kuklinski","year":"2016","unstructured":"Kuklinski LF, Kim J (2016) Expression of PD-L1 in mastocytosis. J Am Acad Dermatol 74(5):1010\u20131012. doi: 10.1016\/j.jaad.2015.09.029","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"8619_CR50","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3324\/haematol.2013.098442","volume":"99","author":"S Bibi","year":"2014","unstructured":"Bibi S, Arslanhan MD, Langenfeld F, Jeanningros S, Cerny-Reiterer S, Hadzijusufovic E, Tchertanov L, Moriggl R, Valent P, Arock M (2014) Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy. Haematologica 99(3):417\u2013429. doi: 10.3324\/haematol.2013.098442","journal-title":"Haematologica"},{"issue":"10","key":"8619_CR51","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.exphem.2013.05.005","volume":"41","author":"EC Chan","year":"2013","unstructured":"Chan EC, Bai Y, Bandara G, Simakova O, Brittain E, Scott L, Dyer KD, Klion AD, Maric I, Gilfillan AM, Metcalfe DD, Wilson TM (2013) KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells. Experimental hematology 41(10):870\u2013881.e872. doi: 10.1016\/j.exphem.2013.05.005","journal-title":"Experimental hematology"},{"issue":"2","key":"8619_CR52","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000048188","volume":"127","author":"M Castells","year":"2002","unstructured":"Castells M, Austen KF (2002) Mastocytosis: mediator-related signs and symptoms. International archives of allergy and immunology 127(2):147\u2013152","journal-title":"International archives of allergy and immunology"},{"key":"8619_CR53","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1744-8069-4-29","volume":"4","author":"WS Shim","year":"2008","unstructured":"Shim WS, Oh U (2008) Histamine-induced itch and its relationship with pain. Mol Pain 4:29. doi: 10.1186\/1744-8069-4-29","journal-title":"Mol Pain"},{"issue":"8","key":"8619_CR54","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/jid.2014.120","volume":"134","author":"L Yang","year":"2014","unstructured":"Yang L, Murota H, Serada S, Fujimoto M, Kudo A, Naka T, Katayama I (2014) Histamine contributes to tissue remodeling via periostin expression. J Invest Dermatol 134(8):2105\u20132113. doi: 10.1038\/jid.2014.120","journal-title":"J Invest Dermatol"},{"issue":"3","key":"8619_CR55","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.iac.2006.05.005","volume":"26","author":"M Castells","year":"2006","unstructured":"Castells M (2006) Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin N Am 26(3):465\u2013485. doi: 10.1016\/j.iac.2006.05.005","journal-title":"Immunol Allergy Clin N Am"},{"key":"8619_CR56","doi-asserted-by":"publisher","first-page":"1682972","DOI":"10.1155\/2016\/1682972","volume":"2016","author":"T Jian","year":"2016","unstructured":"Jian T, Yang N, Yang Y, Zhu C, Yuan X, Yu G, Wang C, Wang Z, Shi H, Tang M, He Q, Lan L, Wu G, Tang Z (2016) TRPV1 and PLC participate in histamine H4 receptor-induced itch. Neural Plast 2016:1682972. doi: 10.1155\/2016\/1682972","journal-title":"Neural Plast"},{"issue":"4","key":"8619_CR57","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","volume":"10","author":"P Bonadonna","year":"2010","unstructured":"Bonadonna P, Zanotti R, Muller U (2010) Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol 10(4):347\u2013353. doi: 10.1097\/ACI.0b013e32833b280c","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"3","key":"8619_CR58","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s11154-016-9394-8","volume":"17","author":"F Hannah-Shmouni","year":"2016","unstructured":"Hannah-Shmouni F, Stratakis CA, Koch CA (2016) Flushing in (neuro)endocrinology. Rev Endocr Metab Disord 17(3):373\u2013380. doi: 10.1007\/s11154-016-9394-8","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"8619_CR59","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/ccr3.505","volume":"4","author":"VK Sukrithan","year":"2016","unstructured":"Sukrithan VK, Salamon JN, Berulava G, Sibinga NE, Verma A (2016) Systemic mastocytosis presenting as cardiac tamponade with CD25(+) pericardial mast cells. Clin Case Rep 4(3):279\u2013281. doi: 10.1002\/ccr3.505","journal-title":"Clin Case Rep"},{"issue":"6","key":"8619_CR60","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/ejh.12544","volume":"94","author":"M Arock","year":"2015","unstructured":"Arock M, Akin C, Hermine O, Valent P (2015) Current treatment options in patients with mastocytosis: status in 2015 and future perspectives. Eur J Haematol 94(6):474\u2013490. doi: 10.1111\/ejh.12544","journal-title":"Eur J Haematol"},{"issue":"7","key":"8619_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00210-016-1247-1","volume":"389","author":"GJ Molderings","year":"2016","unstructured":"Molderings GJ, Haenisch B, Brettner S, Homann J, Menzen M, Dumoulin FL, Panse J, Butterfield J, Afrin LB (2016) Pharmacological treatment options for mast cell activation disease. Naunyn Schmiedeberg's Arch Pharmacol 389(7):671\u2013694. doi: 10.1007\/s00210-016-1247-1","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"issue":"5","key":"8619_CR62","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.clinthera.2013.04.001","volume":"35","author":"M Picard","year":"2013","unstructured":"Picard M, Giavina-Bianchi P, Mezzano V, Castells M (2013) Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes. Clin Ther 35(5):548\u2013562. doi: 10.1016\/j.clinthera.2013.04.001","journal-title":"Clin Ther"},{"issue":"9","key":"8619_CR63","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1111\/all.12672","volume":"70","author":"UB Nurmatov","year":"2015","unstructured":"Nurmatov UB, Rhatigan E, Simons FE, Sheikh A (2015) H1-antihistamines for primary mast cell activation syndromes: a systematic review. Allergy 70(9):1052\u20131061. doi: 10.1111\/all.12672","journal-title":"Allergy"},{"issue":"2","key":"8619_CR64","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.iac.2015.01.010","volume":"35","author":"C Akin","year":"2015","unstructured":"Akin C (2015) Mast cell activation syndromes presenting as anaphylaxis. Immunol Allergy Clin N Am 35(2):277\u2013285. doi: 10.1016\/j.iac.2015.01.010","journal-title":"Immunol Allergy Clin N Am"},{"issue":"5","key":"8619_CR65","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3978\/j.issn.2223-4683.2015.09.03","volume":"4","author":"V Ratner","year":"2015","unstructured":"Ratner V (2015) Mast cell activation syndrome. Transl Androl Urol 4(5):587\u2013588. doi: 10.3978\/j.issn.2223-4683.2015.09.03","journal-title":"Transl Androl Urol"},{"issue":"2","key":"8619_CR66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/ejh.12043","volume":"90","author":"S Verstovsek","year":"2013","unstructured":"Verstovsek S (2013) Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression. Eur J Haematol 90(2):89\u201398. doi: 10.1111\/ejh.12043","journal-title":"Eur J Haematol"},{"issue":"1","key":"8619_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1590\/abd1806-4841.20141847","volume":"89","author":"IC Fernandes","year":"2014","unstructured":"Fernandes IC, Teixeira Mdos A, Freitas I, Selores M, Alves R, Lima M (2014) Adult mastocytosis: a review of the Santo Antonio Hospital\u2019s experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease. An Bras Dermatol 89(1):59\u201366. doi: 10.1590\/abd1806-4841.20141847","journal-title":"An Bras Dermatol"},{"issue":"24","key":"8619_CR68","doi-asserted-by":"publisher","first-page":"5439","DOI":"10.1002\/cncr.26256","volume":"117","author":"A Quintas-Cardama","year":"2011","unstructured":"Quintas-Cardama A, Jain N, Verstovsek S (2011) Advances and controversies in the diagnosis, pathogenesis, and treatment of systemic mastocytosis. Cancer 117(24):5439\u20135449. doi: 10.1002\/cncr.26256","journal-title":"Cancer"},{"issue":"9","key":"8619_CR69","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/modpathol.2011.84","volume":"24","author":"L Sanchez-Munoz","year":"2011","unstructured":"Sanchez-Munoz L, Alvarez-Twose I, Garcia-Montero AC, Teodosio C, Jara-Acevedo M, Pedreira CE, Matito A, Morgado JM, Sanchez ML, Mollejo M, Gonzalez-de-Olano D, Orfao A, Escribano L (2011) Evaluation of the WHO criteria for the classification of patients with mastocytosis. Mod Pathol Off J US Can Acad Pathol Inc 24(9):1157\u20131168. doi: 10.1038\/modpathol.2011.84","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"1","key":"8619_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaci.2015.08.034","volume":"137","author":"K Hartmann","year":"2016","unstructured":"Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Alvarez-Twose I, Matito A, Broesby-Olsen S, Siebenhaar F, Lange M, Niedoszytko M, Castells M, Oude Elberink JN, Bonadonna P, Zanotti R, Hornick JL, Torrelo A, Grabbe J, Rabenhorst A, Nedoszytko B, Butterfield JH, Gotlib J, Reiter A, Radia D, Hermine O, Sotlar K, George TI, Kristensen TK, Kluin-Nelemans HC, Yavuz S, Hagglund H, Sperr WR, Schwartz LB, Triggiani M, Maurer M, Nilsson G, Horny HP, Arock M, Orfao A, Metcalfe DD, Akin C, Valent P (2016) Cutaneous manifestations in patients with mastocytosis: consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. J Allergy Clin Immunol 137(1):35\u201345. doi: 10.1016\/j.jaci.2015.08.034","journal-title":"J Allergy Clin Immunol"},{"issue":"19","key":"8619_CR71","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1056\/NEJMc1510021","volume":"373","author":"TC Theoharides","year":"2015","unstructured":"Theoharides TC, Valent P, Akin C (2015) Mast cells, mastocytosis, and related disorders. N Engl J Med 373(19):1885\u20131886. doi: 10.1056\/NEJMc1510021","journal-title":"N Engl J Med"},{"issue":"6","key":"8619_CR72","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","volume":"67","author":"I Alvarez-Twose","year":"2012","unstructured":"Alvarez-Twose I, Vano-Galvan S, Sanchez-Munoz L, Morgado JM, Matito A, Torrelo A, Jaen P, Schwartz LB, Orfao A, Escribano L (2012) Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis. Allergy 67(6):813\u2013821. doi: 10.1111\/j.1398-9995.2012.02812.x","journal-title":"Allergy"},{"issue":"10","key":"8619_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076116","volume":"8","author":"A Matito","year":"2013","unstructured":"Matito A, Morgado JM, Alvarez-Twose I, Sanchez-Munoz L, Pedreira CE, Jara-Acevedo M, Teodosio C, Sanchez-Lopez P, Fernandez-Nunez E, Moreno-Borque R, Garcia-Montero A, Orfao A, Escribano L (2013) Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome. PLoS One 8(10):e76116. doi: 10.1371\/journal.pone.0076116","journal-title":"PLoS One"},{"issue":"2","key":"8619_CR74","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5152\/tpa.2015.2332","volume":"50","author":"G Tuysuz","year":"2015","unstructured":"Tuysuz G, Ozdemir N, Apak H, Kutlubay Z, Demirkesen C, Celkan T (2015) Childhood mastocytosis: results of a single center. Turk pediatri arsivi 50(2):108\u2013113. doi: 10.5152\/tpa.2015.2332","journal-title":"Turk pediatri arsivi"},{"issue":"3","key":"8619_CR75","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/jid.2012.394","volume":"133","author":"S W\u00f6hrl","year":"2013","unstructured":"W\u00f6hrl S, Moritz KB, Bracher A, Fischer G, Stingl G, Loewe R (2013) A c-kit mutation in exon 18 in familial mastocytosis. J Invest Dermatol 133(3):839\u2013841. doi: 10.1038\/jid.2012.394","journal-title":"J Invest Dermatol"},{"issue":"40","key":"8619_CR76","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3238\/arztebl.2008.0686","volume":"105","author":"HP Horny","year":"2008","unstructured":"Horny HP, Sotlar K, Valent P, Hartmann K (2008) Mastocytosis: a disease of the hematopoietic stem cell. Dtsch Arztebl Int 105(40):686\u2013692. doi: 10.3238\/arztebl.2008.0686","journal-title":"Dtsch Arztebl Int"},{"issue":"4","key":"8619_CR77","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/modpathol.2010.224","volume":"24","author":"K Sotlar","year":"2011","unstructured":"Sotlar K, Cerny-Reiterer S, Petat-Dutter K, Hessel H, Berezowska S, Mullauer L, Valent P, Horny HP (2011) Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol Off J US Can Acad Pathol Inc 24(4):585\u2013595. doi: 10.1038\/modpathol.2010.224","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"6","key":"8619_CR78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039468","volume":"7","author":"DS Moura","year":"2012","unstructured":"Moura DS, Sultan S, Georgin-Lavialle S, Barete S, Lortholary O, Gaillard R, Hermine O (2012) Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression. PLoS One 7(6):e39468. doi: 10.1371\/journal.pone.0039468","journal-title":"PLoS One"},{"issue":"3","key":"8619_CR79","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3324\/haematol.2010.034553","volume":"96","author":"R Zanotti","year":"2011","unstructured":"Zanotti R, Bonadonna P, Bonifacio M, Artuso A, Schena D, Rossini M, Perbellini O, Colarossi S, Chilosi M, Pizzolo G (2011) Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis. Haematologica 96(3):482\u2013484. doi: 10.3324\/haematol.2010.034553","journal-title":"Haematologica"},{"issue":"45","key":"8619_CR80","doi-asserted-by":"crossref","first-page":"7005","DOI":"10.3748\/wjg.14.7005","volume":"14","author":"JK Lee","year":"2008","unstructured":"Lee JK, Whittaker SJ, Enns RA, Zetler P (2008) Gastrointestinal manifestations of systemic mastocytosis. World J Gastroenterol 14(45):7005\u20137008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"8619_CR81","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.iac.2014.01.013","volume":"34","author":"A Kovalszki","year":"2014","unstructured":"Kovalszki A, Weller PF (2014) Eosinophilia in mast cell disease. Immunol Allergy Clin N Am 34(2):357\u2013364. doi: 10.1016\/j.iac.2014.01.013","journal-title":"Immunol Allergy Clin N Am"},{"issue":"4","key":"8619_CR82","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/modpathol.2011.192","volume":"25","author":"JM Morgado","year":"2012","unstructured":"Morgado JM, Sanchez-Munoz L, Teodosio CG, Jara-Acevedo M, Alvarez-Twose I, Matito A, Fernandez-Nunez E, Garcia-Montero A, Orfao A, Escribano L (2012) Immunophenotyping in systemic mastocytosis diagnosis: \u2018CD25 positive\u2019 alone is more informative than the \u2018CD25 and\/or CD2\u2019 WHO criterion. Mod Pathol Off J US Can Acad Pathol Inc 25(4):516\u2013521. doi: 10.1038\/modpathol.2011.192","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"},{"issue":"29","key":"8619_CR83","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1200\/jco.2014.55.2018","volume":"32","author":"C Ustun","year":"2014","unstructured":"Ustun C, Reiter A, Scott BL, Nakamura R, Damaj G, Kreil S, Shanley R, Hogan WJ, Perales MA, Shore T, Baurmann H, Stuart R, Gruhn B, Doubek M, Hsu JW, Tholouli E, Gromke T, Godley LA, Pagano L, Gilman A, Wagner EM, Shwayder T, Bornhauser M, Papadopoulos EB, Bohm A, Vercellotti G, Van Lint MT, Schmid C, Rabitsch W, Pullarkat V, Legrand F, Yakoub-Agha I, Saber W, Barrett J, Hermine O, Hagglund H, Sperr WR, Popat U, Alyea EP, Devine S, Deeg HJ, Weisdorf D, Akin C, Valent P (2014) Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. J Clin Oncol Off J Am Soc Clin Oncol 32(29):3264\u20133274. doi: 10.1200\/jco.2014.55.2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"8619_CR84","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/08998280.2014.11929041","volume":"27","author":"L Zhrebker","year":"2014","unstructured":"Zhrebker L, Cooper B, Krause JR (2014) Systemic mastocytosis with associated acute myelogenous leukemia. Proc (Baylor Univ Med Cent) 27(1):22\u201324","journal-title":"Proc (Baylor Univ Med Cent)"},{"issue":"3","key":"8619_CR85","doi-asserted-by":"publisher","first-page":"203a203","DOI":"10.5826\/dpc.0203a03","volume":"2","author":"P Tschandl","year":"2012","unstructured":"Tschandl P, Mullauer L, Kittler H (2012) Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma. Dermatology practical & conceptual 2(3):203a203. doi: 10.5826\/dpc.0203a03","journal-title":"Dermatology practical & conceptual"},{"issue":"1","key":"8619_CR86","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13256-016-1066-5","volume":"10","author":"MA Hermans","year":"2016","unstructured":"Hermans MA, Broijl A, van Daele PL (2016) A unique presentation of pulmonary disease in advanced systemic mastocytosis, proven by the presence of mast cells in bronchoalveolar lavage: a case report. J Med Case Rep 10(1):283. doi: 10.1186\/s13256-016-1066-5","journal-title":"J Med Case Rep"},{"issue":"4","key":"8619_CR87","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.14309\/crj.2016.125","volume":"3","author":"NS Addepally","year":"2016","unstructured":"Addepally NS, Klair JS, Girotra M, Jones J, Aduli F (2016) Systemic mastocytosis causing refractory pruritus in a liver disease patient. ACG case reports journal 3(4):e152. doi: 10.14309\/crj.2016.125","journal-title":"ACG case reports journal"},{"issue":"5","key":"8619_CR88","doi-asserted-by":"publisher","first-page":"E208","DOI":"10.1503\/cmaj.151314","volume":"189","author":"M Lerner","year":"2017","unstructured":"Lerner M, Pal RS, Borici-Mazi R (2017) Kounis syndrome and systemic mastocytosis in a 52-year-old man having surgery. CMAJ: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne 189(5):E208\u2013e211. doi: 10.1503\/cmaj.151314","journal-title":"CMAJ: Canadian Medical Association journal = journal de l\u2019Association medicale canadienne"},{"issue":"3","key":"8619_CR89","first-page":"99","volume":"57","author":"Y Ehara","year":"2014","unstructured":"Ehara Y, Yoshida Y, Tahira M, Yamamoto O (2014) The expression of melanoma inhibitory activity on mast cells in child patients with cutaneous mastocytosis. Yonago Acta Med 57(3):99\u2013101","journal-title":"Yonago Acta Med"},{"issue":"11","key":"8619_CR90","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s00432-015-1988-0","volume":"141","author":"A Hochhaus","year":"2015","unstructured":"Hochhaus A, Baccarani M, Giles FJ, le Coutre PD, Muller MC, Reiter A, Santanastasio H, Leung M, Novick S, Kantarjian HM (2015) Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study. J Cancer Res Clin Oncol 141(11):2047\u20132060. doi: 10.1007\/s00432-015-1988-0","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"8619_CR91","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jaip.2014.03.009","volume":"2","author":"KC Sokol","year":"2014","unstructured":"Sokol KC, Ghazi A, Kelly BC, Grant JA (2014) Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report. J Allergy Clin Immunol Pract 2(3):266\u2013270. doi: 10.1016\/j.jaip.2014.03.009","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"8619_CR92","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.leukres.2008.12.020","volume":"33","author":"A Vega-Ruiz","year":"2009","unstructured":"Vega-Ruiz A, Cortes JE, Sever M, Manshouri T, Quintas-Cardama A, Luthra R, Kantarjian HM, Verstovsek S (2009) Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosis. Leuk Res 33(11):1481\u20131484. doi: 10.1016\/j.leukres.2008.12.020","journal-title":"Leuk Res"},{"issue":"3","key":"8619_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004770","volume":"11","author":"RJ Napier","year":"2015","unstructured":"Napier RJ, Norris BA, Swimm A, Giver CR, Harris WA, Laval J, Napier BA, Patel G, Crump R, Peng Z, Bornmann W, Pulendran B, Buller RM, Weiss DS, Tirouvanziam R, Waller EK, Kalman D (2015) Low doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity. PLoS Pathog 11(3):e1004770. doi: 10.1371\/journal.ppat.1004770","journal-title":"PLoS Pathog"},{"key":"8619_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1477-3163-4-19","volume":"4","author":"PR Pereira","year":"2005","unstructured":"Pereira PR, Odashiro AN, Marshall JC, Correa ZM, Belfort R Jr, Burnier MN Jr (2005) The role of c-kit and imatinib mesylate in uveal melanoma. J Carcinog 4:19. doi: 10.1186\/1477-3163-4-19","journal-title":"J Carcinog"},{"key":"8619_CR95","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40364-016-0056-5","volume":"4","author":"A Yacoub","year":"2016","unstructured":"Yacoub A, Prochaska L (2016) Ruxolitinib improves symptoms and quality of life in a patient with systemic mastocytosis. Biomarker Res 4:2. doi: 10.1186\/s40364-016-0056-5","journal-title":"Biomarker Res"},{"issue":"8","key":"8619_CR96","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/j.1365-2230.2010.03825.x","volume":"35","author":"F Prignano","year":"2010","unstructured":"Prignano F, Troiano M, Lotti T (2010) Cutaneous mastocytosis: successful treatment with narrowband ultraviolet B phototherapy. Clin Exp Dermatol 35(8):914\u2013915. doi: 10.1111\/j.1365-2230.2010.03825.x","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"8619_CR97","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.2353\/ajpath.2009.080953","volume":"175","author":"C Baumgartner","year":"2009","unstructured":"Baumgartner C, Cerny-Reiterer S, Sonneck K, Mayerhofer M, Gleixner KV, Fritz R, Kerenyi M, Boudot C, Gouilleux F, Kornfeld JW, Sillaber C, Moriggl R, Valent P (2009) Expression of activated STAT5 in neoplastic mast cells in systemic mastocytosis: subcellular distribution and role of the transforming oncoprotein KIT D816V. Am J Pathol 175(6):2416\u20132429. doi: 10.2353\/ajpath.2009.080953","journal-title":"Am J Pathol"},{"issue":"15","key":"8619_CR98","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.18632\/oncotarget.2177","volume":"5","author":"N Sharma","year":"2014","unstructured":"Sharma N, Everingham S, Zeng LF, Zhang ZY, Kapur R, Craig AW (2014) Oncogenic KIT-induced aggressive systemic mastocytosis requires SHP2\/PTPN11 phosphatase for disease progression in mice. Oncotarget 5(15):6130\u20136141. doi: 10.18632\/oncotarget.2177","journal-title":"Oncotarget"},{"issue":"1","key":"8619_CR99","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40413-014-0052-x","volume":"8","author":"G Ferrante","year":"2015","unstructured":"Ferrante G, Scavone V, Muscia MC, Adrignola E, Corsello G, Passalacqua G, La Grutta S (2015) The care pathway for children with urticaria, angioedema, mastocytosis. World Allergy Organ J 8(1):5. doi: 10.1186\/s40413-014-0052-x","journal-title":"World Allergy Organ J"},{"key":"8619_CR100","doi-asserted-by":"publisher","unstructured":"Edwards AM, Capkova S (2011) Oral and topical sodium cromoglicate in the treatment of diffuse cutaneous mastocytosis in an infant. BMJ Case Rep. doi: 10.1136\/bcr.02.2011.3910","DOI":"10.1136\/bcr.02.2011.3910"},{"issue":"4","key":"8619_CR101","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/modpathol.2012.199","volume":"26","author":"RJ Ryan","year":"2013","unstructured":"Ryan RJ, Akin C, Castells M, Wills M, Selig MK, Nielsen GP, Ferry JA, Hornick JL (2013) Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications. Mod Pathol Off J US Can Acad Pathol Inc 26(4):533\u2013543. doi: 10.1038\/modpathol.2012.199","journal-title":"Mod Pathol Off J US Can Acad Pathol Inc"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8619-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8619-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8619-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T04:18:56Z","timestamp":1659241136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8619-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["8619"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8619-2","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}